1261080-26-5
Chemical Structure
Naltrexone-d3
- CAS No.: 1261080-26-5
- Formula:C20H20D3NO4
- Molecular Weight:344.42
IUPAC Name: (4R,4aS,7aR,12bS)-3-((cyclopropyl-1-d)methyl-d2)-4a,9-dihydroxy-2,3,4,4a,5,6-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7(7aH)-one
InChIKey: DQCKKXVULJGBQN-VOVHGNGRSA-N
SMILES: O[C@]12[C@@]34C5=C(C[C@@]2([H])N(CC4)C([2H])([2H])C6([2H])CC6)C=CC(O)=C5O[C@@]3([H])C(CC1)=O
Biological Activity: Naltrexone-d3 is a deuterated labeled Naltrexone (HY-76711)[1]. Naltrexone is an antagonist of Opioid receptor. Naltrexone inhibits cell proliferation in vivo. Naltrexone reduces tumor growth by interfering with cell signalling and modifying the immune system[2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Naltrexone-d3 | Naltrexone-d3 is a deuterated labeled Naltrexone (HY-76711). Naltrexone is an antagonist of Opioid receptor. Naltrexone inhibits cell proliferation in vivo. Naltrexone reduces tumor growth by interfering with cell signalling and modifying the immune system. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Naltrexone (Standard) | ≥98% | Naltrexone (Standard) is the analytical standard of Naltrexone (HY-76711). This product is intended for research and analytical applications. Naltrexone is an orally active, long-acting opioid receptor (opioid receptor) antagonist. Naltrexone blocks the euphoric effects of exogenous opioids and reduces alcohol craving by blocking opioid receptors (μ, κ, and δ) as well as opioid growth factor receptors. Low doses of Naltrexone are used to relieve chronic pain, treat inflammatory diseases and inhibit tumor growth, while high doses or continuous administration exert pro-inflammatory or pro-proliferative effects. Naltrexone relieves intractable pruritus caused by psoriasis, atopic dermatitis and other conditions, and its combination with Bupropion (HY-B0403) inhibits food craving, thereby reducing body weight. |
||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Naltrexone-d4 | 99.82% | Naltrexone-d4 is deuterium labeled Naltrexone (HY-76711). Naltrexone is an orally active, long-acting opioid receptor (opioid receptor) antagonist. Naltrexone blocks the euphoric effects of exogenous opioids and reduces alcohol craving by blocking opioid receptors (μ, κ, and δ) as well as opioid growth factor receptors. Low doses of Naltrexone are used to relieve chronic pain, treat inflammatory diseases and inhibit tumor growth, while high doses or continuous administration exert pro-inflammatory or pro-proliferative effects. Naltrexone relieves intractable pruritus caused by psoriasis, atopic dermatitis and other conditions, and its combination with Bupropion (HY-B0403) inhibits food craving, thereby reducing body weight. |
||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Naltrexone | 99.82% | Naltrexone is an orally active, long-acting opioid receptor (opioid receptor) antagonist. Naltrexone blocks the euphoric effects of exogenous opioids and reduces alcohol craving by blocking opioid receptors (μ, κ, and δ) as well as opioid growth factor receptors. Low doses of Naltrexone are used to relieve chronic pain, treat inflammatory diseases and inhibit tumor growth, while high doses or continuous administration exert pro-inflammatory or pro-proliferative effects. Naltrexone relieves intractable pruritus caused by psoriasis, atopic dermatitis and other conditions, and its combination with Bupropion (HY-B0403) inhibits food craving, thereby reducing body weight. |
||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
